Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mutation, Missense | 7 | 2026 | 91 | 2.840 |
Why?
|
| Protein Stability | 5 | 2025 | 48 | 1.640 |
Why?
|
| Protein Binding | 6 | 2026 | 1082 | 1.090 |
Why?
|
| Apolipoprotein E3 | 1 | 2025 | 12 | 0.960 |
Why?
|
| Apolipoprotein E4 | 1 | 2025 | 67 | 0.900 |
Why?
|
| Congenital Hypothyroidism | 1 | 2024 | 4 | 0.840 |
Why?
|
| Genome, Human | 2 | 2016 | 144 | 0.820 |
Why?
|
| Thyroid Neoplasms | 1 | 2024 | 50 | 0.790 |
Why?
|
| Peptides | 1 | 2026 | 372 | 0.750 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2022 | 3 | 0.750 |
Why?
|
| Peroxidase | 1 | 2022 | 57 | 0.740 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 81 | 0.710 |
Why?
|
| Computational Biology | 4 | 2016 | 327 | 0.620 |
Why?
|
| Alzheimer Disease | 1 | 2025 | 1001 | 0.540 |
Why?
|
| Mutation | 4 | 2025 | 1177 | 0.520 |
Why?
|
| Genetic Variation | 2 | 2025 | 430 | 0.430 |
Why?
|
| Humans | 22 | 2026 | 43102 | 0.410 |
Why?
|
| Head and Neck Neoplasms | 2 | 2025 | 81 | 0.400 |
Why?
|
| Mutagenesis | 2 | 2022 | 91 | 0.370 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 135 | 0.330 |
Why?
|
| Models, Molecular | 3 | 2017 | 876 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 386 | 0.260 |
Why?
|
| Binding Sites | 4 | 2024 | 671 | 0.260 |
Why?
|
| Peroxiredoxins | 1 | 2026 | 11 | 0.240 |
Why?
|
| Sequence Alignment | 1 | 2025 | 272 | 0.230 |
Why?
|
| Pyrimidinones | 1 | 2025 | 15 | 0.230 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2026 | 89 | 0.220 |
Why?
|
| Conserved Sequence | 1 | 2025 | 122 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 63 | 0.220 |
Why?
|
| Pyridones | 1 | 2025 | 50 | 0.210 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 188 | 0.210 |
Why?
|
| Viral Envelope Proteins | 1 | 2025 | 91 | 0.210 |
Why?
|
| Iodide Peroxidase | 1 | 2024 | 40 | 0.210 |
Why?
|
| Interferon Type I | 1 | 2023 | 18 | 0.210 |
Why?
|
| Immunotoxins | 1 | 2023 | 13 | 0.210 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 423 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 159 | 0.200 |
Why?
|
| Antibodies, Neutralizing | 1 | 2024 | 127 | 0.200 |
Why?
|
| Thermodynamics | 3 | 2021 | 229 | 0.200 |
Why?
|
| Amino Acid Sequence | 1 | 2025 | 1180 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2026 | 968 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 515 | 0.190 |
Why?
|
| Multiple Sclerosis | 1 | 2023 | 50 | 0.190 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 306 | 0.180 |
Why?
|
| Neutrophils | 1 | 2022 | 145 | 0.170 |
Why?
|
| Nucleocapsid Proteins | 1 | 2020 | 12 | 0.170 |
Why?
|
| Cattle | 1 | 2022 | 498 | 0.170 |
Why?
|
| Lymphotoxin-alpha | 1 | 2019 | 4 | 0.160 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 29 | 0.160 |
Why?
|
| Mass Screening | 1 | 2024 | 541 | 0.150 |
Why?
|
| Viral Proteins | 1 | 2020 | 190 | 0.150 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1081 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2022 | 561 | 0.140 |
Why?
|
| Static Electricity | 1 | 2017 | 86 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 101 | 0.130 |
Why?
|
| ROC Curve | 2 | 2017 | 159 | 0.130 |
Why?
|
| Internet | 2 | 2016 | 236 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2023 | 863 | 0.120 |
Why?
|
| Animals | 6 | 2025 | 16992 | 0.120 |
Why?
|
| Quality Control | 1 | 2016 | 42 | 0.120 |
Why?
|
| Software | 1 | 2016 | 236 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2013 | 103 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2013 | 74 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 310 | 0.090 |
Why?
|
| Phenotype | 3 | 2022 | 780 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 526 | 0.080 |
Why?
|
| Protein Folding | 1 | 2011 | 123 | 0.080 |
Why?
|
| Neurons | 1 | 2017 | 1263 | 0.080 |
Why?
|
| Gene Expression | 1 | 2013 | 701 | 0.080 |
Why?
|
| Liver | 1 | 2013 | 511 | 0.080 |
Why?
|
| Brain | 1 | 2013 | 1472 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2025 | 119 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2025 | 408 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 734 | 0.050 |
Why?
|
| Autophagy | 1 | 2025 | 140 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2025 | 347 | 0.050 |
Why?
|
| Prognosis | 1 | 2026 | 861 | 0.050 |
Why?
|
| Mice | 2 | 2025 | 6644 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 307 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 92 | 0.040 |
Why?
|
| Phylogeny | 1 | 2025 | 769 | 0.040 |
Why?
|
| Vero Cells | 1 | 2020 | 112 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2020 | 154 | 0.040 |
Why?
|
| Human Genome Project | 1 | 2019 | 7 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Hominidae | 1 | 2019 | 12 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2019 | 86 | 0.040 |
Why?
|
| Africa | 1 | 2019 | 82 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2019 | 206 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2019 | 121 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 197 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2020 | 383 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2025 | 1455 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 307 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2017 | 9 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 2676 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 34 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2017 | 34 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 93 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 72 | 0.030 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 47 | 0.030 |
Why?
|
| Apoptosis | 1 | 2025 | 1568 | 0.030 |
Why?
|
| Tubulin | 1 | 2017 | 96 | 0.030 |
Why?
|
| Microtubules | 1 | 2017 | 121 | 0.030 |
Why?
|
| Drosophila | 1 | 2017 | 152 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 416 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 150 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 506 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 206 | 0.030 |
Why?
|
| Smoking | 1 | 2022 | 1024 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 188 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 456 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 307 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2023 | 2157 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 3994 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 41 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2017 | 392 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2013 | 112 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1596 | 0.020 |
Why?
|
| Thionucleosides | 1 | 2010 | 1 | 0.020 |
Why?
|
| Spermine Synthase | 1 | 2010 | 3 | 0.020 |
Why?
|
| Middle Aged | 1 | 2026 | 12222 | 0.020 |
Why?
|
| Adenosine | 1 | 2010 | 62 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 561 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 712 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 115 | 0.020 |
Why?
|
| Male | 1 | 2026 | 23409 | 0.010 |
Why?
|
| Female | 1 | 2026 | 24698 | 0.010 |
Why?
|